# References

This list standardizes citations used across the repository. Format: FirstAuthor et al. Journal. Year. (Notes).

## Hemodynamics and Physiology
- Su et al. Br J Anaesth. 2023. (mechanistic hemodynamic interaction model). [PubMed](https://pubmed.ncbi.nlm.nih.gov/37355412/)
- Beloeil et al. Br J Anaesth. 2005. (norepinephrine PK/PD in septic shock/trauma). [PubMed](https://pubmed.ncbi.nlm.nih.gov/16227334/)
- Clutter et al. J Clin Invest. 1980. (epinephrine cardiovascular effects). [PubMed](https://pubmed.ncbi.nlm.nih.gov/6995479/)
- Ebert et al. Anesthesiology. 1995. (sevoflurane cardiovascular responses). [PubMed](https://pubmed.ncbi.nlm.nih.gov/7486143/)
- ESC/ERS Task Force. Eur Heart J. 2022. (RHC normal ranges; RAP 2–6 mmHg, PVR 0.3–2.0 WU). [Journal](https://academic.oup.com/eurheartj/article/43/38/3618/6673929)
- Segeroth et al. Eur Heart J Cardiovasc Imaging. 2023. (Pulmonary transit time; median ~6.8 s with normal biventricular EF). [PubMed](https://pubmed.ncbi.nlm.nih.gov/36662127/)
- Koganov et al. Crit Care Med. 1997. (PEEP raises pulmonary vascular resistance). [PubMed](https://pubmed.ncbi.nlm.nih.gov/9187594/)
- Carlsson et al. Acta Anaesthesiol Scand. 1985. (Hypoxic pulmonary vasoconstriction; PVR increases with unilateral hypoxia). [PubMed](https://pubmed.ncbi.nlm.nih.gov/3993324/)
- Sessler. Anesthesiology. 2000. (perioperative heat balance). [PubMed](https://pubmed.ncbi.nlm.nih.gov/10691247/)
- Frank et al. JAMA. 1997. (perioperative thermoregulation). [PubMed](https://pubmed.ncbi.nlm.nih.gov/9087467/)
- Anderson et al. Paediatr Anaesth. 2017. (phenylephrine PK; PD here is heuristic). [PubMed](https://pubmed.ncbi.nlm.nih.gov/28868789/)
- Magnani et al. J Int Med Res. 1977. (dobutamine dose-response; ↑CO, low-dose SV increase without HR change). [PubMed](https://pubmed.ncbi.nlm.nih.gov/838109/)
- Baim et al. N Engl J Med. 1983. (milrinone hemodynamics; ↑CI, ↓SVR). [PubMed](https://pubmed.ncbi.nlm.nih.gov/6888453/)
- Martin et al. Acta Anaesthesiol Scand. 1990. (hyperdynamic septic shock: SVR <= 600; target 700-800 dyn·s/cm^5). [PubMed](https://pubmed.ncbi.nlm.nih.gov/2389659/)
- Melo et al. Crit Care. 1999. (septic shock low SVR cohort: mean SVR ~445 dyn·s/cm^5). [PubMed](https://pubmed.ncbi.nlm.nih.gov/11056727/)
- Bellissant et al. Clin Pharmacol Ther. 2000. (septic shock pressor hyporesponsiveness: phenylephrine Emax ~39 vs 84 mmHg controls). [PubMed](https://pubmed.ncbi.nlm.nih.gov/11014411/)
- Margarson et al. J Appl Physiol (1985). 2002. (septic shock TER of albumin ~6.7%/h). [PubMed](https://pubmed.ncbi.nlm.nih.gov/11960967/)
- Persichini et al. Crit Care Med. 2012. (mean systemic pressure decreases with reduced norepinephrine in septic shock). [PubMed](https://pubmed.ncbi.nlm.nih.gov/22926333/)

## Volatile Anesthetics (PBPK and MAC)
- Davis and Mapleson. Br J Anaesth. 1981. (physiological model of inhaled anesthetics). [PubMed](https://pubmed.ncbi.nlm.nih.gov/7225273/)
- Mapleson. Br J Anaesth. 1996. (age-related MAC formula). [PubMed](https://pubmed.ncbi.nlm.nih.gov/8777094/)
- Yasuda et al. Anesth Analg. 1991. (sevoflurane vs isoflurane uptake/washout). [PubMed](https://pubmed.ncbi.nlm.nih.gov/1994760/)
- Carpenter et al. Anesth Analg. 1986. (inhaled anesthetic kinetics in humans). [PubMed](https://pubmed.ncbi.nlm.nih.gov/3706798/)
- Eger et al. Anesthesiology. 1980. (MAC of nitrous oxide in humans; ~1.04 atm absolute). [PubMed](https://pubmed.ncbi.nlm.nih.gov/7201254/)
- Schuh. Side effects of nitrous oxide (author's transl). 1975. (blood:gas partition coefficient of N2O ~0.47). [PubMed](https://pubmed.ncbi.nlm.nih.gov/1190419/)
- Goto et al. Anesthesiology. 2000. (MACawake of nitrous oxide ~63% at 1 atm). [PubMed](https://pubmed.ncbi.nlm.nih.gov/11046204/)
- Katoh et al. Br J Anaesth. 1997. (Sevo MACawake ~0.63%; N2O 45% reduces MACawake ~50%, less than additive). [PubMed](https://pubmed.ncbi.nlm.nih.gov/9389264/)

## PK / PD Models (IV Agents, Vasopressors)
- Marsh et al. Br J Anaesth. 1991. (propofol PK). [PubMed](https://pubmed.ncbi.nlm.nih.gov/1859758/)
- Schnider et al. Anesthesiology. 1998. (propofol PK). [PubMed](https://pubmed.ncbi.nlm.nih.gov/9605675/)
- Eleveld et al. Br J Anaesth. 2018. (propofol PK/PD). [PubMed](https://pubmed.ncbi.nlm.nih.gov/29661412/)
- Servin et al. Br J Anaesth. 1990. (propofol PK in cirrhosis; Vd increases, clearance not significantly reduced). [PubMed](https://pubmed.ncbi.nlm.nih.gov/2223333/)
- Hiraoka et al. Br J Clin Pharmacol. 2005. (renal extraction of propofol; kidneys ~1/3 of total clearance). [PubMed](https://pubmed.ncbi.nlm.nih.gov/16042671/)
- Minto et al. Anesthesiology. 1997. (remifentanil PK). [PubMed](https://pubmed.ncbi.nlm.nih.gov/9009936/)
- Dershwitz et al. Anesthesiology. 1996. (remifentanil PK/PD in severe liver disease; PK unchanged). [PubMed](https://pubmed.ncbi.nlm.nih.gov/8638835/)
- Hoke et al. Anesthesiology. 1997. (remifentanil PK in renal failure; PK unchanged, metabolite accumulates). [PubMed](https://pubmed.ncbi.nlm.nih.gov/9316957/)
- Wierda et al. Can J Anaesth. 1991. (rocuronium PK). [PubMed](https://pubmed.ncbi.nlm.nih.gov/1829656/)
- Magorian et al. Anesth Analg. 1995. (rocuronium PK in liver disease; Vd increases, clearance unchanged). [PubMed](https://pubmed.ncbi.nlm.nih.gov/7893030/)
- Robertson et al. Eur J Anaesthesiol. 2005. (rocuronium PK in renal failure; clearance reduced). [PubMed](https://pubmed.ncbi.nlm.nih.gov/15816565/)
- Oualha et al. Br J Clin Pharmacol. 2014. (norepinephrine PK in children). [PubMed](https://pubmed.ncbi.nlm.nih.gov/24802558/)
- Clutter et al. J Clin Invest. 1980. (epinephrine clearance in healthy adults). [PubMed](https://pubmed.ncbi.nlm.nih.gov/6995479/)
- Oualha et al. Br J Clin Pharmacol. 2014. (epinephrine PK in children, post-cardiac surgery). [PubMed](https://pubmed.ncbi.nlm.nih.gov/24456639/)
- Abboud et al. Crit Care. 2009. (epinephrine PK in adult septic shock). [PubMed](https://pubmed.ncbi.nlm.nih.gov/19622169/)
- Li et al. Clin Pharmacokinet. 2024. (norepinephrine PK with propofol interaction). [PubMed](https://pubmed.ncbi.nlm.nih.gov/39465453/)
- Ploeger et al. Anesthesiology. 2009. (sugammadex PK/PD modeling). [PubMed](https://pubmed.ncbi.nlm.nih.gov/19104176/)
- Kleijn et al. Br J Clin Pharmacol. 2011. (sugammadex PK/PD). [PubMed](https://pubmed.ncbi.nlm.nih.gov/21535448/)
- Pühringer et al. Br J Anaesth. 2010. (sugammadex reversal times). [PubMed](https://pubmed.ncbi.nlm.nih.gov/20876699/)
- Plaud et al. Clin Pharmacol Ther. 1995. (PK/PD of rocuronium at vocal cords vs adductor pollicis). [PubMed](https://pubmed.ncbi.nlm.nih.gov/7648768/)
- Fiset et al. Can J Anaesth. 1991. (N2O potentiates vecuronium neuromuscular blockade; ED95 reduction). [PubMed](https://pubmed.ncbi.nlm.nih.gov/1683819/)
- Nguyen-Lee et al. Curr Anesthesiol Rep. 2018. (sugammadex PK review). [Springer](https://link.springer.com/article/10.1007/s40140-018-0266-5)
- Bouillon et al. Anesthesiology. 2004. (propofol/remifentanil interaction for tolerance of laryngoscopy). [PubMed](https://pubmed.ncbi.nlm.nih.gov/15166553/)
- Kern et al. Anesthesiology. 2004. (response surface analysis of propofol-remifentanil interaction). [PubMed](https://pubmed.ncbi.nlm.nih.gov/15166554/)
- FDA NDA 203826 Clinical Pharmacology Review. 2012. (phenylephrine PK). [Drugs@FDA](https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/203826_phenylephrine_toc.cfm)
- Hengstmann and Goronzy. Eur J Clin Pharmacol. 1982. (phenylephrine PK). [PubMed](https://pubmed.ncbi.nlm.nih.gov/7056280/)
- Vasopressin injection label (DailyMed). (Vd 0.14 L/kg; CL 9–25 mL/min/kg; t1/2 ≤10 min). [DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=971f9b1c-6094-4f80-920b-cb5d7e62950a)
- Kates and Leier. Clin Pharmacol Ther. 1978. (dobutamine PK in severe CHF; CL 2.35 L/min/m^2; Vd 0.20 L/kg; t1/2 ~2 min). [PubMed](https://pubmed.ncbi.nlm.nih.gov/699477/)
- Daly et al. Am J Cardiol. 1997. (dobutamine plasma concentrations vs dose, 5–30 µg/kg/min). [PubMed](https://pubmed.ncbi.nlm.nih.gov/9165162/)
- Dobutamine injection label (Clinical Pharmacology). (rapid onset/offset; t1/2 ~2 min). [Pfizer Medical Information](https://www.pfizermedicalinformation.com/patient/dobutamine/clinical-pharmacology)
- Milrinone lactate injection label (DailyMed). (Vd 0.38–0.45 L/kg; CL ~0.13 L/kg/hr; t1/2 2.3–2.4 h; hemodynamic improvement within ~5–15 min). [DailyMed](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=88f78780-399f-4780-be19-205739db1682&version=21)

## Respiratory Control and BIS
- Kanazawa et al. J Anesth. 2017. (BIS at age-adjusted 1 MAC desflurane vs sevoflurane). [PubMed](https://pubmed.ncbi.nlm.nih.gov/28791477/)
- Ryu et al. Anesthesiology. 2018. (BIS and SPI at 1 MAC desflurane vs sevoflurane under tetanic stimulation). [PubMed](https://pubmed.ncbi.nlm.nih.gov/29509579/)
- Ryu et al. Br J Anaesth. 2018. (remifentanil requirements at 1 MAC desflurane vs sevoflurane). [PubMed](https://pubmed.ncbi.nlm.nih.gov/30336856/)
- Paraskeva et al. J Clin Anesth. 2005. (BIS ~30 at 1.5 MAC sevoflurane; physostigmine no effect). [PubMed](https://pubmed.ncbi.nlm.nih.gov/16427526/)
- Schwab et al. Anesth Analg. 2004. (BIS response to sevoflurane). [PubMed](https://pubmed.ncbi.nlm.nih.gov/15562061/)
- Olofsen et al. Anesthesiology. 2002. (remifentanil does not change sevo BIS C50). [PubMed](https://pubmed.ncbi.nlm.nih.gov/11873028/)
- Barr et al. Br J Anaesth. 1999. (N2O can produce LOC without lowering BIS). [PubMed](https://pubmed.ncbi.nlm.nih.gov/10562773/)
- Hirota et al. Eur J Anaesthesiol. 1999. (Adding N2O to propofol–fentanyl: BIS changes are small/variable). [PubMed](https://pubmed.ncbi.nlm.nih.gov/10713872/)
- Ozcan et al. J Neurosurg Anesthesiol. 2010. (Sevo or propofol + N2O: BIS/entropy effects modest). [PubMed](https://pubmed.ncbi.nlm.nih.gov/20844378/)
- Babenco et al. Anesthesiology. 2000. (opioid effects on ventilatory control). [PubMed](https://pubmed.ncbi.nlm.nih.gov/10691225/)
- Lee et al. Korean J Anesthesiol. 2011. (propofol effect-site EC50 for respiratory depression). [PubMed](https://pubmed.ncbi.nlm.nih.gov/21927681/)
- Blouin et al. Anesthesiology. 1993. (propofol depresses hypoxic ventilatory response). [PubMed](https://pubmed.ncbi.nlm.nih.gov/8267192/)
- Nieuwenhuijs et al. Anesthesiology. 2001. (propofol effects on ventilatory control). [PubMed](https://pubmed.ncbi.nlm.nih.gov/11605929/)
- Glass et al. Anesthesiology. 1999. (remifentanil ventilatory depression vs CO2). [PubMed](https://pubmed.ncbi.nlm.nih.gov/10360852/)
- Pandit et al. Br J Anaesth. 1999. (hypercapnic ventilatory response at 0.1 MAC sevoflurane). [PubMed](https://pubmed.ncbi.nlm.nih.gov/10618930/)
- Doi and Ikeda. Anesth Analg. 1987. (sevoflurane depresses CO2 response at 1.1-1.4 MAC). [PubMed](https://pubmed.ncbi.nlm.nih.gov/3826666/)
- Duffin. Respir Physiol Neurobiol. 2011. (ventilatory response modeling). [PubMed](https://pubmed.ncbi.nlm.nih.gov/21514404/)
- Bissinger et al. Anasthesiol Intensivmed Notfallmed Schmerzther. 1993. (curare cleft; capnography vs relaxometry). [PubMed](https://pubmed.ncbi.nlm.nih.gov/7902740/)
- Russell et al. Can J Anaesth. 1990. (PaCO2–EtCO2 gradient during postoperative support). [PubMed](https://pubmed.ncbi.nlm.nih.gov/2115404/)
- Lujan et al. Med Sci Monit. 2008 Sep;14(9):CR485-92. (PaCO2–EtCO2 gradient increases with obstruction; n=120). [PubMed](https://pubmed.ncbi.nlm.nih.gov/18758420/)
- Byrne et al. J Appl Physiol (1985). 2005 Sep;99(3):1112-9. (Resting VO2/MET reference values; large cohort). [PubMed](https://pubmed.ncbi.nlm.nih.gov/15831804/)
- Stein et al. Chest. 1995 Jan;107(1):139-43. (A–a gradient age adjustment formula in PE assessment). [PubMed](https://pubmed.ncbi.nlm.nih.gov/7632205/)
- Stock et al. J Clin Anesth. 1989;1(5):328-32. (PaCO2 rise in anesthetized patients with airway obstruction). [PubMed](https://pubmed.ncbi.nlm.nih.gov/2516732/)
- Kobayashi et al. Masui. 1994 Aug;43(8):1130-4. (Arterial blood gas changes during apnea under anesthesia). [PubMed](https://pubmed.ncbi.nlm.nih.gov/7933492/)
- Miyamura et al. Jpn J Physiol. 1980. (Ventilatory response to CO2 by rebreathing; HCVR slope variability). [PubMed](https://pubmed.ncbi.nlm.nih.gov/6790801/)
- Christie et al. Anesth Analg. 1992. (PSV decreases inspiratory work during GA with spontaneous ventilation). [PubMed](https://pubmed.ncbi.nlm.nih.gov/1632530/)
- Lim et al. Paediatr Anaesth. 2012. (PSV vs spontaneous ventilation via ProSeal LMA in children; improved ventilation). [PubMed](https://pubmed.ncbi.nlm.nih.gov/22380745/)
- Capdevila et al. PLoS One. 2014. (PSV vs CMV/SB with LMA; emergence time/ventilatory function). [PubMed](https://pubmed.ncbi.nlm.nih.gov/25536515/)

## Timing / Performance Metrics
- Hughes et al. Anesthesiology. 1992. (propofol CSHT). [PubMed](https://pubmed.ncbi.nlm.nih.gov/1539843/)
- Egan et al. Anesthesiology. 1993. (remifentanil CSHT). [PubMed](https://pubmed.ncbi.nlm.nih.gov/7902032/)
- Kapila et al. Anesthesiology. 1995. (remifentanil CSHT; PD offset to MV recovery). [PubMed](https://pubmed.ncbi.nlm.nih.gov/7486182/)
- Grundmann et al. Acta Anaesthesiol Scand. 2001 Mar;45(3):320-6. (Remifentanil-based anesthesia recovery profile with propofol). [PubMed](https://pubmed.ncbi.nlm.nih.gov/11207468/)
- Kwon et al. Korean J Anesthesiol. 2018 Jun;71(3):207-212. (Hypercapnia does not shorten emergence time from propofol anesthesia). [PubMed](https://pubmed.ncbi.nlm.nih.gov/29690757/)
- Magorian et al. Anesthesiology. 1993. (rocuronium onset). [PubMed](https://pubmed.ncbi.nlm.nih.gov/7902034/)
- Varvel et al. J Pharmacokinet Biopharm. 1992. (TCI performance metrics). [PubMed](https://pubmed.ncbi.nlm.nih.gov/1588504/)
